• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 3
  • Tagged with
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Avalia??o cl?nica e laboratorial do tratamento com lactulose de c?es com doen?a renal cr?nica / Clinical and laboratorial evaluation of the treatment with lactulosis of dogs with chronic kidney disease

PEREIRA, Juliana de Abreu 27 April 2017 (has links)
Submitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2018-03-15T19:04:01Z No. of bitstreams: 1 2017 - Juliana de Abreu Pereira.pdf: 2216195 bytes, checksum: 788fd1f8f4db4f3012004d0eec09d439 (MD5) / Made available in DSpace on 2018-03-15T19:04:01Z (GMT). No. of bitstreams: 1 2017 - Juliana de Abreu Pereira.pdf: 2216195 bytes, checksum: 788fd1f8f4db4f3012004d0eec09d439 (MD5) Previous issue date: 2017-04-27 / CAPES / Prebiotics, such as lactulosis, may favor the switch on the fermentative pattern of the colonic microbiota from proteolytic to saccharolytic, which allows bigger assimilation of nitrogenous compounds by the microrganisms of the colon. The present study aimed to evaluate, in dogs with CKD, the effect of the continued orally use of lactulosis over the nitrogenous compounds metabolisms?, the iron metabolism and on serum levels of albumin, magnesium, calcium and phosphorus. Twenty-one animals with CKD in IRIS II and III stages, under normal handling and feeding, were clinically and laboratorially evaluated by a 28 days period; divided in three groups according to treatment: T1 ? lactulosis + therapeutic diet, T2 ? lactulosis + standard treatment + therapeutic diet, T3 ? standard treatment + therapeutic diet . For the three groups (T1, T2 and T3), clinical parameters indicated anaemia and body score from regular to bad, according to the disease?s degree, during the hole treatment. The haematological and biochemical?s averages are consistent with common laboratorial findings in nephrophatic patients, with high levels of urea and creatinine; and low leves of haematocrit. For all the evaluated parameters in this study, the averages? variations during the period didn?t show any significant difference between times and treatments, with the exception of the calcemia averages that were greater for T1 group; which may indicate that for this animals? group the monotherapy with lactulosis could have increased the absorption of this mineral in those patients. With regard to iron metabolism, this study?s data revealed that the anaemia found in the dogs throughout the experimental period presented chronicity features, since the groups? means remained within the iron and transferrin references, besides high ferritin averages, without significant differences between groups and moments. The obtained data allowed to conclude that there was no difference between the proposed treatments in relation to clinical state and the biochemical and mineral profiles, such as iron metabolism; which justifies that the action mechanisms of prebiotics in nephrophatic patients should be evaluated with more details. / Prebi?ticos, como a lactulose, podem favorecer a altera??o do padr?o fermentativo da microbiota col?nica de proteol?tico para sacarol?tico; o que possibilita maior assimila??o de compostos nitrogenados pelos microrganismos do c?lon. O presente estudo teve por objetivo avaliar, em c?es com DRC, o efeito da utiliza??o continuada de lactulose por via oral, sobre o metabolismo de compostos nitrogenados; o metabolismo do ferro, e sobre as concentra??es s?ricas de albumina, magn?sio, c?lcio e f?sforo. Vinte e um animais portadores de DRC em est?gios IRIS II e III, com manejo e alimenta??o normais, foram avaliados clinicamente e laboratorialmente por um per?odo de 28 dias; divididos em tr?s grupos conforme o tratamento: T1 ? lactulose + ra??o terap?utica, T2 ? lactulose + tratamento convencional + ra??o terap?utica, T3 ? tratamento convencional + ra??o terap?utica. Para os tr?s grupos (T1, T2 e T3), os par?metros cl?nicos foram indicativos de anemia e escore corporal de regular a ruim, de acordo com o grau da enfermidade, ao longo de todo tratamento. As m?dias dos par?metros hematol?gicos e bioqu?micos s?o condizentes com achados laboratoriais comuns em nefropatas; com elevados valores de ureia e creatinina e valores decrescidos de hemat?crito. Para todos os par?metros as varia??es durante o per?odo n?o apresentaram diferen?a significativa entre os tempos e tratamentos, ? exce??o das m?dias de calcemia que foram maiores para o grupo T1; o que pode indicar que para os animais deste grupo a monoterapia com lactulose pode ter aumentado a absor??o deste mineral. Com rela??o ao metabolismo de ferro, os dados revelaram que a anemia encontrada nos c?es em todo o per?odo experimental apresentou caracter?sticas de cronicidade, uma vez que as m?dias dos grupos permaneceram dentro dos intervalos de refer?ncia para ferro e transferrina; al?m de m?dias elevadas de ferritina, sem diferen?as significativas entre grupos e momentos. Os dados obtidos permitiram concluir que n?o houve diferen?a entre os tratamentos propostos com rela??o ao estado cl?nico e aos perfis bioqu?micos e minerais, bem como ao metabolismo de ferro; o que justifica que os mecanismos de a??o dos prebi?ticos em nefropatas devem ser avaliados com maiores detalhes.
2

Desenvolvimento de requeij?o prebi?tico com adi??o de galactooligossacar?deo / Desenvolvimento de Requeij?o prebi?tico com adi??o de galactooligossacar?deo

Belsito, Pedro Campinho 12 April 2016 (has links)
Submitted by Sandra Pereira (srpereira@ufrrj.br) on 2017-04-10T11:37:49Z No. of bitstreams: 1 2016 - Pedro Campinho Belsito.pdf: 1175009 bytes, checksum: 76927e794a55e13aa297bb3b657cc97b (MD5) / Made available in DSpace on 2017-04-10T11:37:49Z (GMT). No. of bitstreams: 1 2016 - Pedro Campinho Belsito.pdf: 1175009 bytes, checksum: 76927e794a55e13aa297bb3b657cc97b (MD5) Previous issue date: 2016-04-12 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / The aim of this study was to develop a prebiotic ?requeij?o cremoso? cheese with galactooligosaccharide, evaluating the physicochemical, rheological, optical an microstructural as well as the sensory acceptance of the processed products. The ?requeij?o cremoso? cheese was processed and added galactoligossaccharide (0, 1.5%, 3.0%, 4.0% w / w%, respectively) and subjected to physical and chemical analysis (pH, moisture, fat and protein), instrumental color (system L*, a, b), rheology (flow curve, and oscillatory tests), microstructure and sensory analysis ( hedonic test with 80 customers). The results show that there was no significant influence of the treatments with galactooligosaccharide in physicochemical parameters (p > 0.05) of ?requeij?es cremosos? cheeses, while regarding the optical characteristics the addition of GOS provided higher brightness (L*) compared to the added treatments of increasing concentrations of galactooligosaccharide as the highest whiteness index (WI). Regarding the rheological behavior was observed that all samples showed similar behavior, but the ?requeij?o cremoso? cheese control tended to higher shear stress values for shear rate and higher stiffness and storage modulus values . All samples showed curd behavior index (n) less than 1, indicating pseudoplastic behavior, in which the apparent viscosity decreased with increasing applied shear rate. There was an increase in the flow of cheese samples subjected to melting test. From microstructural point of view, the addition of GOS provided a denser and compact matrix protein and the number and size of fat globules reduced while the sensory analysis showed better results in all attributes in the analysis showing potential functional food option for marketing. / A suplementa??o com fibras prebi?ticas constitui-se uma potencial op??o de alimento funcional, dado que um produto com propriedade prebi?tica pode ter um impacto positivo na sa?de gastrointestinal. O objetivo deste trabalho foi o desenvolvimento do requeij?o cremoso adicionado de Galactooligossacar?deo (GOS), avaliando o produto bem como seu efeito nas caracter?sticas f?sico-qu?micas, reol?gicas, ?pticas e na aceita??o sensorial. Requeij?o cremoso foi processado e adicionado de galactoligossacar?deo (0, 1,5% 3,0% 4,0% % p/p, respectivamente) e submetidos a an?lises f?sico-qu?micas (pH , umidade, gordura e prote?na), cor instrumental ( sistema L*, a, b), reologia (curva de fluxo, e ensaios oscilat?rios), microestrutura e an?lise sensorial ( teste hed?nico com 80 consumidores). Os resultados obtidos mostram que n?o houve influ?ncia significativa dos tratamentos com galactooligossacar?deo nos requeij?es nos par?metros f?sico-qu?micos (p>0,05), enquanto com rela??o as caracter?sticas ?pticas a adi??o do GOS proporcionou maior luminosidade (L*) comparada aos tratamentos adicionados de concentra??es crescentes de galactooligossacar?deo assim como o maior ?ndice de brancura (WI). Com rela??o aos aspectos reol?gicos foi poss?vel observar que todas as amostras apresentaram comportamento similar, por?m o requeij?o controle apresentou tend?ncia a maiores valores de tens?o de cisalhamento por taxa de deforma??o e maiores valores de m?dulo de rigidez e estocagem. Todas as amostras de requeij?o apresentaram ?ndices de comportamento (n) menores que 1, indicando comportamento pseudopl?stico, em que a viscosidade aparente diminuiu com o aumento da taxa de deforma??o aplicada. Houve aumento do fluxo de queijo nas amostras submetidas ao teste de derretimento. Do ponto de vista microestrutural, a adi??o de GOS proporcionou uma matriz proteica mais densa e compacta e com o n?mero e tamanho dos gl?bulos de gordura diminu?dos enquanto que na an?lise sensorial foram observados resultados melhores em todos os atributos, mostrando potencial op??o de alimento funcional para a comercializa??o
3

Efeito da lactulose sobre os par?metros cl?nicos e bioqu?micos s?ricos de c?es azot?micos e n?o azot?micos / Effect of lactulose on serum biochemical parameters of healthy dogs and with renal failure

PEREIRA, Juliana de Abreu 29 May 2012 (has links)
Submitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2017-06-02T17:59:31Z No. of bitstreams: 1 2012 - Juliana de Abreu Pereira.pdf: 1955696 bytes, checksum: ebd0d6238112522c3901af5b9de55998 (MD5) / Made available in DSpace on 2017-06-02T17:59:31Z (GMT). No. of bitstreams: 1 2012 - Juliana de Abreu Pereira.pdf: 1955696 bytes, checksum: ebd0d6238112522c3901af5b9de55998 (MD5) Previous issue date: 2012-05-29 / The Chronic Renal Failure (CRF) is characterized by a growing inability of the kidneys to maintain internal homeostasis. The affected animals show major changes as the increase in serum urea, creatinine and phosphorus. Currently, there is no specific treatment for nephropathic. Lactulose, a disaccharide formed by the reaction between fructose and galactose sacarol?ticas is assimilated by bacteria of the intestinal tract and these diminished competition by the population of urease-producing bacteria, limiting the production and absorption of ammonia and urea with consequent reduction in portal blood. Aiming to evaluate the effects of lactulose as adjuvant treatment of dogs with CRF were evaluated parameters indicative of liver function (enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) and renal (urea and creatinine) besides glucose and serum levels of Ca and P in dogs azot?micos not under normal handling and feeding, or not treated with lactulose orally for a period of 30 days, and serum urea and creatinine in dogs with CRF under different protocols therapeutic. feces showed normal color and odor, but diarrhea in animals treated with lactulose. animals as normal renal function, or not treated with lactulose showed no significant changes in blood glucose, serum activities of the enzymes ALT, AST and ALP, and values of urea and creatinine. animals treated with lactulose the phosphorus decreased progressively with a significant difference on days 21 and 30. biochemical analyzes for urea and creatinine nephropathic animals under different treatment protocols showed a reduction of these metabolites in animals of all groups , emphasizing the reduction of uremia and the effect of cetoan?logos and use of prebiotic lactulose in nephropathic dogs. / A Insufici?ncia Renal Cr?nica (IRC) ? caracterizada por uma crescente incapacidade dos rins em manter a homeostasia interna. Os animais acometidos apresentam como principais altera??es o aumento dos n?veis s?ricos de ur?ia, creatinina e f?sforo. Atualmente, n?o existe um tratamento espec?fico para nefropatas. A lactulose, um dissacar?deo formado pela rea??o entre frutose e galactose ? assimilado por bact?rias sacarol?ticas do trato intestinal e estas diminuem por competi??o a popula??o de bact?rias produtoras de urease, limitando a produ??o e absor??o de ur?ia e am?nia com consequente redu??o no sangue portal. Com os objetivos de avaliar os efeitos da lactulose como coadjuvante do tratamento de c?es com IRC foram avaliados os par?metros indicativos da fun??o hep?tica (enzimas alaninoaminotransferase (ALT), aspartatoaminotransferase (AST) e fosfatase alcalina (FA) e renal (ur?ia e creatinina), al?m da glicemia e n?veis s?ricos de Ca e P em c?es n?o azot?micos sob manejo e alimenta??o normais, tratados ou n?o com lactulose por via oral, por um per?odo de 30 dias e os n?veis s?ricos de ur?ia e creatinina de c?es com IRC sob diferentes protocolos terap?uticos. As fezes apresentaram cor e odor normais, por?m diarr?icas nos animais tratados com lactulose. Os animais normais quanto ? fun??o renal, tratados ou n?o com lactulose n?o apresentaram altera??es significativas na glicemia, atividades s?ricas das enzimas ALT, AST e FA; e nos valores de ur?ia e creatinina. Para os animais tratados com lactulose a fosfatemia sofreu redu??o progressiva com diferen?a significativa nos dias 21 e 30. An?lises bioqu?micas para ur?ia e creatinina dos animais nefropatas sob diferentes protocolos de tratamento indicou redu??o desses metab?litos em animais de todos os grupos, destacando-se a redu??o da uremia e o efeito ben?fico dos cetoan?logos e do uso do pr?-bi?tico lactulose em c?es nefropatas.

Page generated in 0.0864 seconds